Pfizer Stock News

Pfizer CEO Albert ​Bourla plans to attend U.S. ‌President Donald Trump's state dinner for Chinese President Xi Jinping on Thursday evening, according ​to a source familiar with ​the matter on Tuesday.

A surge in U.S.-China transactions is drawing scrutiny in Washington, where some lawmakers are pushing to slow the pace of investment.

The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.

Medicus Pharma (NASDAQ:MDCX) earlier this week outlined progress across its SkinJect program and a co-development and licensing opportunity with Pfizer, with CEO Raza Bokhari highlighting clinical, partnership and funding developments as the company sharpens its focus on precision oncology and capital-efficient drug development. Bokhari said final SkinJect results published on ClinicalTrials.go...

Large caps tend to outperform small caps as year's end approaches.

Nearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower prices under deals expected to be announced by President Donald Trump on Monday. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.

U.S. President Donald ​Trump is expected to announce a new round of drug-pricing agreements on Monday, a White ‌House official said, part of a push to make healthcare more affordable for Americans.

The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi and ​Pfizer-BioNTech's updated COVID vaccines, the companies ‌said on Thursday, after an advisory panel recommended that the shots should target ​the dominant XFG variant.